Clinical Trial Update: Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer [Phase 3]

View source ↗

Summary

ClinicalTrials.gov entry indicates a Phase III trial evaluating gemcitabine, curcumin, and celecoxib (Celebrex) in advanced or inoperable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CELEBREX (Celecoxib)
• Curcumin (curcumin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN